PharmaVentures
Episodes
How Strategy and Communication Expedite Deal Outcomes
15 Dec 2025
Contributed by Lukas
Adrian Dawkes talks to PharmaVentures' Founder and CEO, Dr Fintan Walton, about the importance of strategy and preparation in today's deal making spac...
Pharmaceutical Manufacturing: Adaptation Is the Key to Survival
05 Nov 2025
Contributed by Lukas
Join Adrian Dawkes, Managing Director at PharmaVentures, for this podcast episode exploring how the pharmaceutical manufacturing sector is evolving in...
Drug Pricing: Europe vs. US, PBMs, and Direct-to-Patient
22 Sep 2025
Contributed by Lukas
Adrian Dawkes talks to recently appointed PharmaVentures' Vice President, Samara Ferguson, about a hot, often controversial topic: the price of medici...
Navigating Risk in Times of Increased Uncertainty
30 Apr 2025
Contributed by Lukas
Adrian Dawkes talks to PharmaVentures Founder and CEO Fintan Walton about how companies can navigate risk and even deploy new strategies in times of i...
Global Drug Shortages; What are the causes and how do we fix them?
30 Dec 2024
Contributed by Lukas
Fintan Walton, founder and CEO of PharmaVentures chairs a round table discussion on this pressing issue. Â Featuring; Jim Gale. Managing Partner, Sig...
Adrian Dawkes talks to PharmaVentures Founder and CEO Fintan Walton about his experience from over 30 years of dealmaking.
16 Dec 2024
Contributed by Lukas
Adrian Dawkes talks to PharmaVentures Founder and CEO Fintan Walton about his experience from over 30 years of dealmaking. In particular, why innovato...
How is AI changing drug discovery today and where will it go from here?
21 Oct 2024
Contributed by Lukas
Listen as Adrian Dawkes talks to Kurt Herpel, CEO and Klaus Kratochwill, CSO of Delta 4, an Austrian /Swiss based AI tech company. Hear how their AI j...
Pharma/Biotech M&A: Insights and Trends with Soren Demin
24 Sep 2024
Contributed by Lukas
Listen as Soren Demin draws on his 20 years of M&A experience to provide insight into the current Pharma/Biotech M&A landscape. Key topics inc...
The Future of Diagnostics and the Impact on Deals
29 Nov 2023
Contributed by Lukas
Listen as Andreas Katsiamides talks with Adrian Dawkes about the future of diagnostics and the impact on deals. They discuss: Technological advances ...
The Involvement of Law and Tax in Deal Making
25 Oct 2023
Contributed by Lukas
Listen as Colin McCall, Partner - Life Sciences and Deep Tech at Taylor Wessing, and Oliver Pumfrey, Managing Director at FTI Consulting, talk with Ad...
Commercial Due Diligence and the Deal Making Process
27 Sep 2023
Contributed by Lukas
Once you have identified an asset you want to acquire or partner, what happens next?  In this podcast, Ralph Hughes takes the listener through the ...
Financial and Technical Aspects Driving Today’s Life Sciences Deal Making
30 Aug 2023
Contributed by Lukas
Listen as Andrew Guise gives key insight into the deal making landscape -Â asset value, accessing the market, positioning and the actual deal process ...
Current Challenges for CROs and CDMOs in Drug Development and Supply
26 Jul 2023
Contributed by Lukas
Listen as Jansen Jacob, Frank Dollard and Steve Garland discuss the ways in which pharma and biotech companies are getting control back over their sup...
4 Common Mistakes in Partnering
28 Jun 2023
Contributed by Lukas
Listen as Fintan Walton, PharmaVentures’ CEO and Founder, discusses the 4 common mistakes being made in partnering and how to avoid them.  Fintan ...
The Importance of Pricing and Market Access in Licensing, Partnering and Early-Stage Development
17 May 2023
Contributed by Lukas
Listen as Ralph Hughes, PharmaVentures’ Pricing and Market Access expert, talks with Adrian Dawkes about how you can reduce the risk when you want t...
Medical Device and In Vitro Diagnostic Regulations are changing. How will you be affected?
25 Apr 2023
Contributed by Lukas
Listen as Ben Jacoby, Regulatory Expert, talks with Adrian Dawkes about the transition to the new regulations in Europe and UK: Can existing products...
The Korean Partnering Opportunity for Western Biopharmaceutical Companies
03 Apr 2023
Contributed by Lukas
Listen as JungHyun Eom describes the Korean partnering opportunity for western biopharma companies and her exciting new role establishing PharmaVentur...
How to Acquire Companies or Assets Successfully
24 Feb 2023
Contributed by Lukas
In this podcast, PharmaVentures’ deal experts discuss the process of helping clients in the life sciences industry acquire or license assets or righ...
Robust Valuations of Life Science Companies, Assets and Licensing Deals
23 Feb 2023
Contributed by Lukas
Listen as Stephen Waterman and Kyriakos Tzafestas describe how PharmaVentures’ real-world experience combines with valuation models, in-depth co...
Review of 2022: M&A, Licensing and Fundraising
23 Feb 2023
Contributed by Lukas
Listen as Fintan Walton, PharmaVentures’ CEO and Founder, reflects on this year’s deal trends in M&A, Licensing and Fundraising, considers the sig...
The Role of CDMOs in a Fast Evolving Manufacturing Landscape
23 Feb 2023
Contributed by Lukas
Listen as Jansen Jacob and Steve Garland discuss how the future role of CDMOs in biopharmaceutical manufacturing will be affected by the challenges of...
How Your Pricing and Reimbursement Strategy Affects Your Deal Making Success
09 Nov 2022
Contributed by Lukas
Listen as PharmaVentures’ Pricing and Market Access expert, Ralph Hughes, recommends elements of a robust plan to help you achieve the best pricing ...